These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1084 related articles for article (PubMed ID: 10421651)
1. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice. Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134 [TBL] [Abstract][Full Text] [Related]
4. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice. Nomizo A; Postol E; de Alencar R; Cardillo F; Mengel J Immunology; 2005 Oct; 116(2):233-44. PubMed ID: 16162272 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. Hashimoto W; Takeda K; Anzai R; Ogasawara K; Sakihara H; Sugiura K; Seki S; Kumagai K J Immunol; 1995 May; 154(9):4333-40. PubMed ID: 7722291 [TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity. D'Orazio JA; Burke GW; Stein-Streilein J J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788 [TBL] [Abstract][Full Text] [Related]
7. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. Takahashi M; Ogasawara K; Takeda K; Hashimoto W; Sakihara H; Kumagai K; Anzai R; Satoh M; Seki S J Immunol; 1996 Apr; 156(7):2436-42. PubMed ID: 8786302 [TBL] [Abstract][Full Text] [Related]
8. Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection. Teixeira HC; Kaufmann SH J Immunol; 1994 Feb; 152(4):1873-82. PubMed ID: 8120395 [TBL] [Abstract][Full Text] [Related]
9. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells. Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219 [TBL] [Abstract][Full Text] [Related]
10. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. Chen H; Paul WE J Immunol; 1997 Sep; 159(5):2240-9. PubMed ID: 9278312 [TBL] [Abstract][Full Text] [Related]
11. Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. Ogasawara K; Takeda K; Hashimoto W; Satoh M; Okuyama R; Yanai N; Obinata M; Kumagai K; Takada H; Hiraide H; Seki S J Immunol; 1998 Apr; 160(7):3522-7. PubMed ID: 9531314 [TBL] [Abstract][Full Text] [Related]
12. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. Ellison CA; MacDonald GC; Rector ES; Gartner JG J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574 [TBL] [Abstract][Full Text] [Related]
13. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells. Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. Wang M; Ellison CA; Gartner JG; HayGlass KT J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522 [TBL] [Abstract][Full Text] [Related]
15. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation. Moodycliffe AM; Maiti S; Ullrich SE J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987 [TBL] [Abstract][Full Text] [Related]
16. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. Takeda K; Seki S; Ogasawara K; Anzai R; Hashimoto W; Sugiura K; Takahashi M; Satoh M; Kumagai K J Immunol; 1996 May; 156(9):3366-73. PubMed ID: 8617962 [TBL] [Abstract][Full Text] [Related]
17. Predominant appearance of NK1.1+ T cells producing IL-4 may be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection. Enomoto A; Nishimura H; Yoshikai Y J Immunol; 1997 Mar; 158(5):2268-77. PubMed ID: 9036974 [TBL] [Abstract][Full Text] [Related]
18. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731 [TBL] [Abstract][Full Text] [Related]
19. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. Matsui K; Yoshimoto T; Tsutsui H; Hyodo Y; Hayashi N; Hiroishi K; Kawada N; Okamura H; Nakanishi K; Higashino K J Immunol; 1997 Jul; 159(1):97-106. PubMed ID: 9200444 [TBL] [Abstract][Full Text] [Related]
20. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]